ARTICLE | Company News
Pivotal BioSciences, ProteomTech Inc. deal
May 10, 2004 7:00 AM UTC
ProteomTech will use its Pt-Fold technology to develop an E. coli production system for Pivotal's PB1 analog of interleukin-2 (IL-2) to treat cancer. The compound, which Pivotal said is designed to ...